Heritage Trust Co Purchases New Holdings in Revvity, Inc. (NYSE:RVTY)

Heritage Trust Co bought a new position in Revvity, Inc. (NYSE:RVTY - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 12,445 shares of the company's stock, valued at approximately $1,389,000.

A number of other hedge funds have also bought and sold shares of the business. Assetmark Inc. increased its position in shares of Revvity by 3,700.0% during the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock valued at $30,000 after purchasing an additional 259 shares during the last quarter. Millstone Evans Group LLC purchased a new stake in Revvity during the fourth quarter valued at approximately $38,000. Continuum Advisory LLC raised its position in Revvity by 2,972.7% in the third quarter. Continuum Advisory LLC now owns 338 shares of the company's stock worth $43,000 after acquiring an additional 327 shares during the period. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Revvity by 55.9% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock worth $43,000 after acquiring an additional 138 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in shares of Revvity by 33.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company's stock valued at $58,000 after acquiring an additional 131 shares during the period. Hedge funds and other institutional investors own 86.65% of the company's stock.

Insider Buying and Selling at Revvity

In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of the company's stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the sale, the insider now directly owns 33,400 shares in the company, valued at $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. 0.68% of the stock is owned by company insiders.

Remove Ads

Analyst Ratings Changes

A number of brokerages recently commented on RVTY. Sanford C. Bernstein cut Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 target price on the stock. in a report on Friday, January 10th. Raymond James reaffirmed an "outperform" rating and set a $145.00 price objective (up from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Barclays reduced their target price on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. Finally, KeyCorp lifted their price target on shares of Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Four analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $133.75.

Revvity Price Performance

Shares of RVTY traded down $1.75 during midday trading on Wednesday, hitting $93.79. 1,297,929 shares of the company traded hands, compared to its average volume of 1,041,276. Revvity, Inc. has a 52 week low of $89.61 and a 52 week high of $129.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.03 and a current ratio of 3.60. The firm has a 50 day moving average of $108.15 and a 200-day moving average of $114.76. The stock has a market cap of $11.27 billion, a price-to-earnings ratio of 42.44, a PEG ratio of 3.82 and a beta of 1.07.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $1.42 EPS for the quarter, beating analysts' consensus estimates of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same quarter last year, the firm earned $1.25 earnings per share. On average, analysts forecast that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be paid a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity's payout ratio is 12.67%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.